MaxCyte Inc Stock, NASDAQ:MXCT
22 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878
United States of America
Number of Employees:
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Gaithersburg, MD.